Restricted accessBrief reportFirst published online 2026-4
A Children’s Oncology Group Survey Exploring Practices and Barriers to Sperm Banking for Post-Pubertal Males with Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
This study examined sperm banking (SB) practices and barriers for post-pubertal males with high-risk acute lymphoblastic leukemia (ALL) prior to chemotherapy. A cross-sectional survey of 2345 Children’s Oncology Group oncologists across the U.S., Canada, Australia, and New Zealand yielded 572 responses. While 78% offer SB, common barriers include timing (70%) and patient health (44%). Most institutions offering SB have a dedicated oncofertility team (57%), and 86% are medium- or large-sized, suggesting greater resource availability. These results extend prior research by identifying actionable barriers and informing targeted interventions to improve access to FP for post-pubertal males with ALL.
KlipsteinS, FallatME, SavelliS, COMMITTEE ON BIOETHICS, SECTION ON HEMATOLOGY/ONCOLOGY, SECTION ON SURGERY. Fertility preservation for pediatric and adolescent patients with cancer: Medical and ethical considerations. Pediatrics, 2020; 145(3):e20193994; doi: 10.1542/peds.2019-3994
2.
LorenAW, SenapatiS. Fertility preservation in patients with hematologic malignancies and recipients of hematopoietic cell transplants. Blood, 2019; 134(9):746–760; doi: 10.1182/blood.2018846790
3.
FrederickNN, KloskyJL, MeachamL, et al.Fertility preservation practices at pediatric oncology institutions in the united states: A report from the children’s oncology Group. JCO Oncol Pract, 2023; 19(4):e550–e558; doi: 10.1200/OP.22.00349
4.
SuHI, LacchettiC, LetourneauJ, et al.Fertility preservation in people with cancer: ASCO guideline update. J Clin Oncol, 2025; 43(12):1488–1515; doi: 10.1200/JCO-24-02782
5.
NahataL, HalpernJA, BendleK, et al.The case for pre-treatment sperm banking as standard of care for all post-pubertal males with cancer. J Adolesc Young Adult Oncol, 2025; 14(2):125–128; doi: 10.1089/jayao.2024.0100
6.
FrederickNN, KloskyJL, MeachamLR, et al.Infrastructure of fertility preservation services for pediatric cancer patients: A report from the children’s oncology group. JCO Oncol Pract, 2022; 18(3):e325–e333; doi: 10.1200/OP.21.00275
7.
LambertiniM, PeccatoriFA, DemeestereI, et al.; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†. Ann Oncol, 2020; 31(12):1664–1678; doi: 10.1016/j.annonc.2020.09.006
8.
BahkJY, JungJH, JinLM, MinSK. Cut-off value of testes volume in young adults and correlation among testes volume, body mass index, hormonal level, and seminal profiles. Urology, 2010; 75(6):1318–1323; doi: 10.1016/j.urology.2009.12.007
9.
Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: A committee opinion. Fertil Steril, 2019; 112(6):1022–1033; doi: 10.1016/j.fertnstert.2019.09.013
10.
MeachamLR, BurnsK, OrwigKE, LevineJ. Standardizing Risk assessment for treatment-related gonadal insufficiency and infertility in childhood adolescent and young adult cancer: The pediatric initiative network risk stratification system. J Adolesc Young Adult Oncol, 2020; 9(6):662–666; doi: 10.1089/jayao.2020.0012
11.
CloseA, BurnsK, BjornardK, et al.Fertility preservation in pediatric leukemia and lymphoma: A report from the Children’s Oncology Group. Pediatr Blood Cancer, 2023; 70(8):e30407; doi: 10.1002/pbc.30407
